# Dog Heartworm and Flea Prevention: Integrated Parasite Control ## Key Takeaways - Integrated parasite control for dogs strategically combines chemoprophylaxis, environmental management, and diagnostic surveillance to combat *Dirofilaria immitis* (heartworm) and *Ctenocephalides felis* (cat flea). - *Dirofilaria immitis* is transmitted by mosquitoes, with larvae developing through L3 and L4 stages before maturing into adults in the pulmonary arteries, causing pulmonary hypertension and right ventricular hypertrophy. - *Ctenocephalides felis* has a four-stage life cycle (egg, larva, pupa, adult), with eggs, larvae, and pupae developing off-host in the environment, and adults being obligate hematophagous ectoparasites. - Diagnosis of heartworm infection relies on antigen testing (ELISA), microfilarial detection (modified Knott's test), and imaging, while flea infestation is diagnosed by visual identification of fleas or flea feces. - Oral endectocides, often combining macrocyclic lactones (MLs) with isoxazolines, are the cornerstone of prevention, providing >99% efficacy against heartworm and rapid flea kill, though ML resistance in *D. immitis* is an emerging concern. - Effective flea control necessitates treating all in-contact animals and implementing environmental management, including vacuuming and washing bedding, to address immature life stages. --- ## Introduction Integrated parasite control for dogs represents a strategic approach that combines chemoprophylaxis, environmental management, and diagnostic surveillance to mitigate the health impacts of both endoparasites and ectoparasites [1, 2]. The two primary targets of such programs are *Dirofilaria immitis*, the causative agent of [canine heartworm disease](/knowledge/parasites/pet-parasites/canine-heartworm-disease-dirofilaria-immitis-reference), and *Ctenocephalides felis*, the cat flea, which is the most common ectoparasite infesting dogs in many regions [3, 4]. The convergence of prevention for these two parasites into single oral formulations, commonly referred to as the [dog heartworm and flea pill](/knowledge/parasites/pet-parasites/canine-dirofilaria-immitis-flea-control-integrated-prevention-strategies), has revolutionized compliance and broadened the scope of prophylactic veterinary medicine [5, 6]. This article provides an exhaustive review of the biological, chemical, and clinical foundations of integrated parasite control, with a focus on the mechanisms of action, diagnostic modalities, and emerging challenges such as macrocyclic lactone (ML) resistance [7, 8]. ## Etiology and Life Cycle of Target Parasites ### Dirofilaria immitis *Dirofilaria immitis* is a filarial nematode transmitted by mosquitoes of the genera *Aedes*, *Culex*, and *Anopheles* [9, 10]. The life cycle begins when a female mosquito ingests microfilariae (first-stage larvae, L1) from an infected canine host during a blood meal [11]. Within the mosquito, larvae develop through L2 and L3 stages over approximately 10 to 14 days, with development rate dependent on ambient temperature and humidity [12, 13]. Infective L3 larvae are deposited onto the skin of a new host during subsequent feeding and actively penetrate the bite wound [14]. Larvae migrate through subcutaneous tissues, molt to L4 within 9 to 12 days, and then to L5 (immature adults) by 50 to 70 days post-infection [15]. Adult worms reside in the pulmonary arteries and right ventricle, where they can survive for 5 to 7 years [16]. Female worms produce microfilariae that circulate in the peripheral blood, completing the transmission cycle [17]. ### Ctenocephalides felis *Ctenocephalides felis* is a holometabolous insect with four life stages: egg, larva, pupa, and adult [18]. Adult fleas are obligate hematophagous ectoparasites that reside on the host, while eggs, larvae, and pupae develop off-host in the environment [19]. Eggs are laid on the host but fall into the environment, hatching into larvae within 2 to 5 days [20]. Larvae feed on organic debris and adult flea feces (dried blood), progressing through three instars before pupating [21]. The pupal stage is protected within a silk cocoon and can remain dormant for extended periods, emerging in response to mechanical pressure, heat, and carbon dioxide [22]. The entire life cycle can be completed in as little as 18 days under optimal conditions [23]. ## Epidemiology and Transmission Dynamics The geographic distribution of *D. immitis* is expanding, driven by climate change, increased vector ranges, and movement of infected animals [24, 25]. Seroprevalence studies in Spain have demonstrated nationwide exposure, with significant regional variation linked to temperature, precipitation, and irrigation practices [2]. In Portugal and Spain, socio-environmental factors such as urbanization, proximity to water bodies, and dog density have been identified as key predictors of transmission risk [4]. Emergence of *D. immitis* in previously non-endemic areas, including humid coastal zones and northern latitudes, has been documented through molecular characterization and entomological surveillance [15, 26]. The first reported case of *D. immitis* in a coyote (*Canis latrans*) from Prince Edward Island highlights the role of wildlife reservoirs in disease spread [3]. In Asia, high burdens of canine hemoparasitic infections, including *D. immitis*, have been reported in free-roaming dog populations in Thailand, with spatial clustering indicating focal transmission [27]. Similarly, serological and molecular detection in pet dogs from Lahore, Pakistan, confirms endemicity in South Asia [18]. Co-infections with *Dirofilaria repens* and other filariids are increasingly recognized, complicating diagnosis and treatment [20, 28]. Flea infestations are ubiquitous in domestic environments, with prevalence influenced by climate, housing conditions, and the presence of other pets [25]. The cat flea is a vector for multiple pathogens, including *[Bartonella henselae](/knowledge/bacteria/pet-bacteria/bartonella-henselae-cat-scratch-disease-clinical-zoonosis)*, *Rickettsia felis*, and the cestode *Dipylidium caninum* [29]. Integrated control programs must therefore address both the direct dermatological effects of flea infestation and the vector-borne disease risks [30]. ## Clinical Signs and Pathology ### Heartworm Disease The clinical manifestations of [canine heartworm disease](/knowledge/parasites/pet-parasites/canine-heartworm-disease-dirofilaria-immitis-reference) are directly related to the location and burden of adult worms within the pulmonary vasculature [31]. Early infection is often subclinical, but as worm burden increases, pathological changes include pulmonary endarteritis, intimal proliferation, and thrombosis [32]. These changes lead to increased pulmonary vascular resistance, pulmonary hypertension, and right ventricular hypertrophy [33]. Clinical signs include exercise intolerance, cough, dyspnea, syncope, and in severe cases, caval syndrome resulting from massive worm burdens obstructing blood flow through the right heart [34]. A case report of gastric dilatation and volvulus in a dog with situs inversus and concurrent heartworm disease illustrates the complex interactions between cardiovascular pathology and gastrointestinal emergencies [13]. In cats, infection with immature *D. immitis* can cause severe respiratory distress, and computed tomography assessment of bronchial lumen and pulmonary artery relationships has been used to characterize these changes [24]. Pulmonary vascular proliferative lesions have also been described in wild raccoon dogs, providing a comparative model for disease pathology [35]. ### Flea Infestation Flea infestation causes pruritus, dermatitis, and alopecia, primarily in the lumbosacral region, tail head, and medial thighs [19]. Flea allergy dermatitis (FAD) is a type I and type IV hypersensitivity reaction to flea salivary antigens, resulting in severe pruritus, erythema, papules, and secondary pyoderma [22]. Chronic exposure can lead to lichenification and hyperpigmentation [23]. Additionally, fleas serve as intermediate hosts for *D. caninum*, and heavy infestations can cause iron-deficiency anemia in young or debilitated animals [18]. ## Diagnostic Approaches ### Heartworm Diagnostics Diagnosis of *D. immitis* infection relies on a combination of antigen testing, microfilarial detection, and imaging [5, 9]. Commercial enzyme-linked immunosorbent assays (ELISAs) detect circulating adult female worm antigens, with high sensitivity and specificity in dogs with mature infections [5]. Point-of-care antigen tests using fresh whole blood have been assessed for consistency compared to archived sera, with results indicating reliable performance across sample types [5]. Novel point-of-care tests, such as those based on immunochromatographic principles, have been compared to the modified Knott's test for detection of both *D. immitis* and *D. repens* [9]. The modified Knott's test remains the gold standard for microfilarial identification and quantification, allowing differentiation of *D. immitis* from *Dipetalonema reconditum* [22]. Molecular diagnostics, including conventional PCR and [loop-mediated isothermal amplification](/knowledge/diagnostics/molecular/lamp-assay-rapid-detection-african-swine-fever-virus-oral-fluids) (LAMP) targeting the cytochrome c oxidase subunit I (COI) gene, offer high sensitivity and specificity for epidemiological studies [21]. LAMP assays are particularly advantageous for field deployment due to their rapid turnaround time and minimal equipment requirements [21]. Metabolomic analysis of ML-susceptible and -resistant *D. immitis* isolates has identified potential biomarkers for resistance detection, representing a novel diagnostic frontier [31]. Serological evidence of *Wolbachia* endosymbionts, which are essential for worm fertility and survival, can also be used as an adjunct diagnostic marker [1, 32]. ### Flea Diagnostics Diagnosis of flea infestation is primarily based on visual identification of adult fleas or flea feces (flea dirt) on the animal [19]. A flea comb can be used to collect specimens for microscopic identification [22]. In cases of FAD, intradermal skin testing or serological testing for flea-specific IgE can confirm hypersensitivity [23]. However, the presence of fleas on the animal is not always necessary for diagnosis, as intermittent grooming may remove evidence of infestation [18]. ## Integrated Parasite Control Strategies ### Chemoprophylaxis: The [Dog Heartworm and Flea Pill](/knowledge/parasites/pet-parasites/canine-heartworm-and-flea-prevention-understanding-combined-products) The cornerstone of integrated parasite control is the administration of oral endectocides that provide activity against both nematodes and arthropods [10, 11]. These formulations, commonly referred to as the [dog heartworm and flea pill](/knowledge/parasites/pet-parasites/canine-heartworm-disease-and-flea-control-combined-preventive-therapies), combine an ML (e.g., ivermectin, moxidectin, or selamectin) with an isoxazoline (e.g., afoxolaner, sarolaner, or lotilaner) or other ectoparasiticide [16]. The ML component acts by binding to glutamate-gated chloride channels in nematode and arthropod nerve and muscle cells, causing hyperpolarization, paralysis, and death of microfilariae and developing larval stages of *D. immitis* [19]. The isoxazoline component inhibits gamma-aminobutyric acid (GABA)-gated chloride channels in insects, providing rapid and sustained flea kill [16]. Efficacy studies have demonstrated that monthly administration of these combination products provides >99% prevention of heartworm infection when administered consistently [10, 11]. A sustained-release formulation of ivermectin has shown efficacy in preventing heartworm infection in endemic areas of Italy [10]. Comparative efficacy trials of sarolaner/moxidectin/pyrantel versus afoxolaner/moxidectin/pyrantel against an ML-resistant *D. immitis* isolate have demonstrated that both combinations maintain high efficacy, though resistance can reduce prophylactic margins [11]. A novel chewable tablet containing lotilaner, moxidectin, praziquantel, and pyrantel has also been shown to be effective for heartworm prevention, expanding the therapeutic arsenal [16]. ### Mechanisms of Action and Resistance Macrocyclic lactones exert their anthelmintic and insecticidal effects through allosteric modulation of invertebrate ligand-gated ion channels [19]. Resistance to MLs in *D. immitis* is an emerging concern, with resistant isolates characterized by reduced susceptibility to moxidectin and ivermectin [11, 31]. Metabolomic profiling of susceptible and resistant isolates has revealed alterations in energy metabolism, including changes in glycolysis, the tricarboxylic acid cycle, and oxidative phosphorylation [31]. These metabolic adaptations may allow resistant worms to survive drug exposure by circumventing the neurotoxic effects of MLs [19]. The development of non-arsenical adulticide protocols using moxidectin and doxycycline, which targets the *Wolbachia* endosymbiont, represents an alternative therapeutic approach for managing resistant infections [14]. A systematic review and meta-analysis of these protocols has provided evidence for their efficacy, though further research is needed to standardize treatment regimens [14]. ### Flea Control and Environmental Management Effective flea control requires a multimodal approach that includes treatment of all in-contact animals and environmental management [22]. Adulticides kill adult fleas on the host, while insect growth regulators (IGRs) such as lufenuron or pyriproxyfen prevent egg hatching and larval development [23]. Environmental control involves vacuuming, washing bedding, and applying environmental insecticides to areas where fleas develop [18]. The integration of flea control with heartworm prevention in a single oral product simplifies administration and improves owner compliance [5, 6]. ### Diagnostic Surveillance and Monitoring Annual testing for heartworm infection is recommended for all dogs, regardless of prevention status, to detect breakthrough infections and monitor for resistance [5, 9]. Antigen testing should be performed at least 6 months after the last possible exposure to allow for the maturation of adult worms [5]. In dogs with suspected ML resistance, microfilarial testing and molecular characterization of the isolate are indicated [21, 31]. Monitoring of flea populations through periodic examination and owner reporting allows for timely adjustments to the control program [22]. ## Treatment of Established Infections ### Adulticide Therapy Treatment of adult *D. immitis* infection traditionally involves administration of melarsomine dihydrochloride, an arsenical adulticide [14]. However, due to the potential for adverse reactions, including pulmonary thromboembolism, treatment must be carefully managed with strict exercise restriction [34]. Non-arsenical protocols using moxidectin and doxycycline have been developed as alternatives, particularly for cases where melarsomine is contraindicated or where ML resistance is suspected [14]. These protocols aim to eliminate adult worms through a combination of direct microfilaricidal activity, *Wolbachia* depletion, and host immune response [1, 14]. ### Microfilaricidal Therapy Microfilariae must be eliminated to prevent transmission and to reduce the risk of anaphylactic reactions following adulticide therapy [19]. Macrocyclic lactones are effective microfilaricides, but their use in microfilaremic dogs requires caution due to the potential for rapid microfilarial death and associated adverse reactions [11]. Doxycycline, by targeting *Wolbachia*, indirectly reduces microfilarial production and viability [1, 14]. ### Surgical Intervention In cases of caval syndrome, where a large mass of adult worms obstructs the right heart, surgical removal via jugular venotomy or fluoroscopically guided retrieval is necessary [13]. This procedure carries significant anesthetic and surgical risks but is life-saving in acute cases [34]. ## Emerging Challenges and Future Directions ### Macrocyclic Lactone Resistance The emergence of ML-resistant *D. immitis* isolates in the United States and other regions poses a significant threat to heartworm prevention programs [11, 31]. Resistance appears to be polygenic, involving mutations in P-glycoprotein transporters and target-site insensitivity [19]. Ongoing research into the metabolomic and genomic basis of resistance aims to identify biomarkers for early detection and to guide the development of novel anthelmintics [31]. ### Climate Change and Vector Expansion Climate change is expanding the geographic range of mosquito vectors, leading to the emergence of heartworm in previously low-risk areas [4, 15]. Predictive modeling using socio-environmental factors can help identify regions at risk and guide targeted prevention efforts [4]. Entomological surveillance for *Dirofilaria* spp. in mosquito populations provides early warning of transmission risk [8, 26]. ### One Health Perspectives Heartworm disease is a One Health issue, as *D. immitis* can infect many mammalian hosts, including wild canids, felids, and occasionally humans [17, 32]. Wildlife reservoirs, such as raccoon dogs and coyotes, complicate control efforts by maintaining transmission cycles in sylvatic environments [3, 32, 35]. A bibliometric analysis of global *D. immitis* research within the One Health framework has highlighted the need for interdisciplinary collaboration between veterinary, medical, and environmental scientists [17]. ## Conclusion Integrated parasite control for dogs, centered on the [dog heartworm and flea pill](/knowledge/parasites/pet-parasites/canine-heartworm-disease-and-flea-prevention), represents a highly effective strategy for preventing two of the most common and clinically significant parasitic infections in companion animals. The success of these programs depends on a thorough understanding of parasite biology, consistent administration of chemoprophylaxis, environmental management, and vigilant diagnostic surveillance. Emerging challenges, including ML resistance and climate-driven vector expansion, necessitate ongoing research and adaptation of control protocols. By integrating molecular diagnostics, metabolomic profiling, and [epidemiological modeling](/knowledge/bioinformatics/epidemiological-modeling-lessons-from-the-spanish-flu-to-covid-19), the veterinary profession can continue to refine and optimize integrated parasite control for the benefit of canine health and public health. ## References [1] Loku Gamage N, Ranasinghe K, Rodrigo W. Molecular Characterization of Wolbachia Endosymbionts and Their Association With [Canine Dirofilariasis](/knowledge/parasites/pet-parasites/canine-dirofilariasis-heartworm-current-diagnostics-prevention) in Colombo District, Sri Lanka. J Parasitol Res. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42328691/ [2] Montoya-Matute A, Checa R, Gómez-Velasco C, et al. Nationwide seroprevalence of canine vector-borne pathogens in dogs in Spain. Parasit Vectors. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42289747/ [3] Leaman LJ, Graham KF, Jones MEB, et al. First reported case of Dirofilaria immitis in a coyote (Canis latrans) from Prince Edward Island. Can Vet J. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42266338/ [4] Morchón R, Balmori-de la Puente A, Infante González-Mohino E, et al. Deciphering the socio-environmental factors associated with realized heartworm transmission risk in dogs from Portugal and Spain. Front Vet Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42254907/ [5] Falkiner A, Finlayson J, Caraguel C, et al. Consistency assessment of a canine heartworm point-of-care antigen test using fresh whole blood and archived sera. Vet Parasitol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42248054/ [6] Nonnis F, Corda A, Zeinoun P, et al. [Feline heartworm disease](/knowledge/parasites/pet-parasites/heartworm-disease-cats-diagnostic-challenges-treatment-options) in endemic settings: an integrated diagnostic approach. Res Vet Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42225012/ [7] Cole PA, Fraser C, Wallace ML, et al. Primary surgical bleeding and platelet function are unchanged in heartworm-infected dogs. Front Vet Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42182912/ [8] Cavallo L, Perugini E, Nonnis F, et al. Entomological survey of Dirofilaria spp. in Sardinia (Italy): molecular detection and mosquito species distribution. Parasit Vectors. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42104410/ [9] Sanders TL, Starnes A, Kelly MA, et al. Comparative performance of the novel, point-of-care Pluslife Mini Dock Dirofilaria immitis/Dirofilaria repens detection test with the modified Knott's test in dogs. Parasit Vectors. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42104384/ [10] Genchi M, Venco L, Fozzer M, et al. Efficacy and safety of a sustained-release formulation of ivermectin (FILAPREV®) in preventing heartworm infection (Dirofilaria immitis) in dogs in two endemic areas of Italy. Parasit Vectors. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42087229/ [11] Rodriguez J, Jones S, Mahabir S, et al. Comparative efficacy of six monthly doses of Simparica Trio(®) (sarolaner, moxidectin, and pyrantel chewable tablets) versus NexGard(®) Plus (afoxolaner, moxidectin, and pyrantel chewable tablets) against a macrocyclic lactone-resistant Dirofilaria immitis isolate in dogs. Parasit Vectors. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42087216/ [12] Szabó KÉ, Aresu L, Müller L, et al. Clinico-pathological and renal morphological findings in dogs naturally infected with Dirofilaria repens. BMC Vet Res. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42069630/ [13] Stokowski S, Steuri SK, Lux C, et al. Gastric Dilatation and Volvulus and Heartworm Disease in a Dog With Situs Inversus. Vet Radiol Ultrasound. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42011803/ [14] Santiwattanatarm T, Sakcamduang W, Kongkaew C, et al. A systematic review and meta-analysis of non-arsenical adulticide protocols using moxidectin and doxycycline for the treatment of adult heartworm infection in dogs. Curr Res Parasitol Vector Borne Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42007372/ [15] Monteiro ACMP, Ribeiro CM, Fehlberg HF, et al. Emergence of Dirofilaria immitis in humid coastal zones: Epidemiological predictors and molecular characterization. Vet J. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41990946/ [16] Young L, Reinemeyer CR, Abdelmoneim M, et al. Efficacy of a novel chewable tablet (Credelio Quattro™) containing lotilaner, moxidectin, praziquantel, and pyrantel for the prevention of heartworm disease (Dirofilaria immitis) in dogs. Parasit Vectors. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41943128/ [17] Aguilar-Elena R, Rodríguez-Escolar I, Collado-Cuadrado M, et al. Mapping Global Trends in Dirofilaria immitis Research Within the One Health Framework (1945-2025): A Bibliometric Perspective. Animals (Basel). 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41897965/ [18] Safdar I, Ur Rehman S, Roman U, et al. Serological and molecular detection of Dirofilaria immitis in pet dogs of Lahore, Pakistan. Ann Parasitol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41881496/ [19] Geary TG. Current issues in heartworm chemotherapy. Parasit Vectors. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41851772/ [20] Zanfagnini LG, Chocobar MLE, Schmidt EMS, et al. Unveiling filariid infections in dogs living in the Western Amazon, Brazil. Comp Immunol Microbiol Infect Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41818949/ [21] Genc MG, Erol U, Sahın OF, et al. Application of COI-LAMP for Detection of Dirofilaria immitis with High Sensitivity and Specificity in Epidemiological Studies. Acta Parasitol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41801609/ [22] Roya GM, Yagoob G, Bahram AT. Seasonal study of Blood Parasites: DirofilariaImmitis and Dipetalonema Reconditum in the Guard Dogs of Tabriz city, Iran. Arch Razi Inst. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41769291/ [23] Campbell E, Dzimianski M, Greenway K, et al. Transient Intraperitoneal Residence of Dirofilaria immitis Larvae in the Mongolian Gerbil (Meriones unguiculatus). Pathogens. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41754451/ [24] García-Rodríguez SN, Matos JI, García-Guasch L, et al. Computed Tomography Assessment of the Bronchial Lumen-Vertebral Body and Pulmonary Artery-Vertebral Body Relationships in Cats Naturally Infected with Immature Dirofilaria immitis. Vet Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41745980/ [25] Di Cesare A, Astuti C, Morelli S, et al. Serological Evidence of Selected Tick-Borne Pathogens and Dirofilaria immitis in Owned Dogs from Italy and Greece. Vet Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41745927/ [26] Hammond NG, Todaro A, Fairbanks KA, et al. Mosquito (Diptera: Culicidae) surveillance for Dirofilaria immitis (Rhabditida: Onchocercidae) using a zoo as a focus for operational detection in central Utah. J Med Entomol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41723581/ [27] Kongtawee R, Junsiri W, Narapakdeesakul D, et al. High burden and spatial clustering of canine hemoparasitic infections in southern Thailand: A molecular survey of free-roaming dogs. One Health. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41737196/ [28] Rajković M, Rajković V, Bogunović D. Dirofilaria immitis and Dirofilaria repens co-infection in a microfilaremic dog from Negotin, Eastern Serbia: Unusual localization of adult Dirofilaia repens in an abdominal hernia sac. Vet Parasitol Reg Stud Reports. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41741045/ [29] Martínez-Durán D, Mujika M, Morales M, et al. Vector-borne pathogens in Spanish greyhounds from Central Spain: Prevalence and hematobiochemical findings. Vet Parasitol Reg Stud Reports. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41741046/ [30] Kim J, Kim M, Lee S, et al. Feline heartworm (Dirofilaria immitis) infection in stray cats in Ulsan, Korea. Parasites Hosts Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41668261/ [31] Kumar S, Pang Z, Siciliani E, et al. Metabolomic analysis of macrocyclic lactone susceptible and resistant isolates of Dirofilaria immitis. Int J Parasitol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41655616/ [32] Ryu J, Lee H, Lee HK, et al. Epidemiological survey of Dirofilaria immitis and its Wolbachia endosymbiont in wild raccoon dogs in Seoul, Korea, with emphasis on lung tissue-based detection. Parasitology. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41645674/ [33] Nakhale M, Hess JA, Oliver E, et al. Development of Dirofilaria immitis adult worms in NSG mice, detection of parasite-derived microRNA and comparative analysis of laboratory isolates. Sci Rep. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41617897/ [34] Chocobar MLE, Eckersall DP, Panarese R, et al. Comparison of Haptoglobin Concentrations Between Microfilaremic and Amicrofilaremic Dogs Infected by Dirofilaria immitis. Vet Clin Pathol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41612543/ [35] Tangchang W, Song JY, Kim DH, et al. Pulmonary Vascular Proliferative Lesions in Wild Korean Raccoon Dogs (Nyctereutes procyonoides): Description of 13 Cases. Vet Sci. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41600677/ ## Related Clinical & Scientific Guides * [Tick-Borne Diseases in Dogs: Pathogens, Clinical Signs, Diagnosis, and Prevention](/knowledge/parasites/general/tick-borne-diseases-dogs) * [Toxoplasmosis in Cats and the Risk of Brain Infection in Humans](/knowledge/parasites/general/toxoplasmosis-cats-brain-infection-humans) * [Dog Heartworm and Tick-Borne Disease Prevention](/knowledge/parasites/general/dog-heartworm-and-tick-borne-disease-prevention)